期刊文献+

盐霉素对乳腺癌转移的抑制作用 被引量:2

Inhibitory effect of salinomycin on invasion of breast cancer ceils
原文传递
导出
摘要 目的观察盐霉素对乳腺癌细胞株MCF-7、MCF-7/ADR、MDA—MB-231的体外增殖和侵袭能力的影响,探讨其对乳腺癌细胞的转移抑制作用。方法用细胞计数试剂盒(CCK-8)法检测细胞增殖,得出半数抑制浓度(IC50)值;用Transwell小室法检测侵袭能力的变化;分别用实时定量聚合酶链反应(Real—timePCR)法和Westernblot法检测ETS1和基质金属蛋白酶(MMP)-1基因和蛋白的表达变化。结果盐霉素抑制乳腺癌细胞的增殖,3种细胞的IC50值分别为(7.47±0.64)、(5.11±0.97)、(4.08±0.85)μmoL/L;经不同浓度的盐霉素处理后,3种细胞侵袭能力逐渐下降,分别为对照组的65.9%/41.9%、55.8%/37.8%、48.5%/24.6%;MCF-7/ADR和MDA—MB-231的ETS1和MMP-1表达水平随着盐霉素浓度升高而下降。结论盐霉素可以抑制乳腺癌细胞的增殖,降低其侵袭能力。 Objective To study the effects of salinomycin on the proliferation and invasion of breast cancer cells and the mechanism. Methods The human breast cancer cells MCF-7, MCF-7/ADR and MDA-MB-231, were treated with salinomycin. Cell viability was determined by cell counting kit-8. The invasive ability of tumor cells was evaluated by Transwell chamber assay. The mRNA and protein levels of ETS1 and matrix metalloproteinase (MMP) -1 were detected by using real-time quantitative polymerase chain reaction (Real-time PCR) and Western blotting respectively. Results Salinomycin significantly in- hibited the proliferation of breast cancer cells with the IC50 value being (7.47 ±0. 64) for MCF-7, (5. 11 ±0. 97) for MCF-7/ADR, and (4. 08 ±0. 85) μmol/L for MDA-MB-231, respectively. The invasion capac- ity of breast cancer cells were significantly reduced by salinomycin (65.9%/41.9% for MCR-7, 55.8%/ 37.8% for MCR-7/ADR, and 48. 5%/24. 6% for MDA-MB-231, respectivel). Simustaneously, the ex- pression levels of ETS1 and MMP-1 were downregulated by salinomycin. Conclusion Salinomyein can in- hibit the proliferation of breast cancer cells, and reduce the invasion capacity.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第8期1635-1637,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30801116/H1622)
关键词 乳腺癌 盐霉素 增殖 侵袭 Breast cancer Salinomycin Proliferation Invasion
  • 相关文献

参考文献14

  • 1Zhang GN,Liang Y,Zhou LJ,et al.Combination of salinomycin andgemcilabine eliminates pancreatic cancer cells.Cancer Letl,2011,313:137-144.
  • 2Kim KY,Yu SN,Lee SY,et al.Salinomycin-induced apoptosis of hu-man prostate cancer cells due to accumulated reactive oxygen speciesand mitochondrial membrane depolarization.Biochem Biophys ResCommun,2011,413:80-86.
  • 3Wang Y.Effects of salinomycin on cancer stem cell in human lung ad-enocarcinoma A549 cells.Med Chem,2011,7:106-111.
  • 4Tang QL,Zhao ZQ,Li JC,et al.Salinomycin inhibits osteosarcoma bytargeting its tumor stem cells.Cancer Lett,2011,311:113-121.
  • 5Dong IT,Zhou HM,Wang LL,et al.Salinomycin selectively targets‘CD133 + ’ cell suhpopulations and decreases malignant traits incolorectal cancer lines.Ann Surg Oncol,2011,18:1797-1804.
  • 6Fuchs D,Daniel V,Sadeghi M,et al.Salinomycin overcomes ABCtransporter-mediated multidrug and apoptosis resistance in human leu-kemia stem cell-like KG-la cells.Biochem Biophys Res Commun,20I0,394:1098-1104.
  • 7Fuchs D,Heinold A,Opelz G,et al.Salinomycin induces apoptosisand overcomes apoptosis resistance in human cancer cells.BiochemBiophys Kes Commun,2009,390:743-749.
  • 8Seth A,Watson DK.ETS transcription factors and their emerging rolesin human cancer.Eur J Cancer,2005,41:2462-2478.
  • 9丁印鲁,李兆亭,宫向前.ets-1反义寡核苷酸对胃癌细胞株SGC-7901侵袭力的影响[J].中华实验外科杂志,2003,20(9):785-786. 被引量:2
  • 10Sementchenko VI,Watson DK.Ets target genes:past,present and fu-ture.Oncogene,2000,19 ;6533-6548.

二级参考文献16

  • 1林志雄,陈锦峰,张鹏飞,吴翊钦,王玮.星形细胞瘤生物学行为特征及机理探讨[J].微侵袭神经外科杂志,1997,2(1):44-50. 被引量:12
  • 2刘安民,吴启华,李方成,钟志光.脑膜瘤肿瘤血管形成及瘤周水肿与基质金属蛋白酶-9表达的关系[J].中华实验外科杂志,2005,22(4):465-466. 被引量:11
  • 3阎庆辉,王磊,赵晶,王铁,薛平,王凤安.RAB5A、基质金属蛋白酶-9在大肠癌中的表达及其关系[J].中华实验外科杂志,2006,23(7):805-806. 被引量:7
  • 4Colognam H, Yurchenco PD. Form and funcation:the laminin family of heterotrimers. Dev Uyn ,2000,218:213-234.
  • 5McKnight TR,von dem Bussche MH,Vigheron DB, et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg, 2002, 97: 794-802.
  • 6Pei Y, Harvey A, Yu XP, et al. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibi- tors in human chondrosarcoma ceils : potential role of Runx2 in mediating 1338 effects. Osteoarthritis Cartilage, 2006, 14 : 749-758.
  • 7Fong YC, Dutton CM, Cha SS, et al. Prognostic significance of a single nucleotide polymorphism in the MMP-1 promoter in ehondrosarcoma. J Bone Joint Surg Br Proceedings, 2005,87 : 298 -299.
  • 8Nakayama T, Ito M, Ohtsuru A, et al. Expression of the ets-1 protooncogene in human gastric carcinoma: correlation with tumor invasion.Am J Pathol, 1996, 149 : 1931-1939.
  • 9Kamitani H, Masuzawa H, Kanazawa I, et al. Recurrence of convexity merdngiomas:tumor cells in the arachnoid membrane. Surg Neurol,2001,56: 228 -235.
  • 10Michaelis SA, Okuducu AF, Sarioglu NM, et al. The transcription factor Ets-1 is expressed in human amniochorionic membranes and is upregulated in term and preterm premature rupture of membranes. J Perinat Med,2005 ,33 :314-319.

共引文献1

同被引文献18

  • 1PICCI P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis, 2007.2:6.
  • 2MIRABELLO L, TROISI R J, SAVAGE S A. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program [J]. Cancer,2009,115(7):1 531-1 543.
  • 3FERNANDEZ-PINEDA I, BAHRAMI A, GREEN J F, et al. Isolated subcutaneous metastasis of osteosarcoma 5 years after initial diagnosis [J]. J Pediatr Surg,2011,46 ( 10): 2 029-2 031.
  • 4HANAHAN D,WEINBERG R A. Hallmarks of cancer: t- he next generation[J]. Cell,2011,144(5):646-674.
  • 5ZHANG B,WANG X,CAI F,et al. Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK [J]. Tumour Biol,2012,33 (6):1 855-1 862.
  • 6GUPTA P B,ONDER T T,JIANG G,et aL Identification of selective inhibitors of cancer stem cells by high-throughput screening[ J ]. Cell, 2009,138(4):645-659.
  • 7DONG T T,ZHOU H M,WANG L L,et al. Salinomycin selectivdy targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines [J]. Ann Surg Oncol,201 I, 18(6): 1 797- 1 804.
  • 8Lyman GI-I, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update [ J]. J Clin Onco1,2014, 32 (13) : 1365-1383.
  • 9Tozaki M. Diagnosis of breast eancer: MDCT versus MRI [ J ]. Breast Cancer,2008,15(3) :205-211.
  • 10Tozaki M, Uchida K, Yamashita A, et al. Three-dimensional fusion imaging of lymphoscintigraphy and MDCT for sentinel node biopsy in breast cancer [ J ]. Nihon Igaku Hoshasen Gakkai Zasshi, 2003,63 (8) :412-414.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部